These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10027684)

  • 1. Validation of seven graded diary cards for severity of dyspeptic symptoms in patients with non ulcer dyspepsia.
    Junghard O; Lauritsen K; Talley NJ; Wiklund IK
    Eur J Surg Suppl; 1998; (583):106-11. PubMed ID: 10027684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia. The Canadian Cisapride Nud Study Group.
    Champion MC; MacCannell KL; Thomson AB; Tanton R; Eberhard S; Sullivan SN; Archambault A
    Can J Gastroenterol; 1997 Mar; 11(2):127-34. PubMed ID: 9113812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a 7-point Global Overall Symptom scale to measure the severity of dyspepsia symptoms in clinical trials.
    Veldhuyzen van Zanten SJ; Chiba N; Armstrong D; Barkun AN; Thomson AB; Mann V; Escobedo S; Chakraborty B; Nevin K
    Aliment Pharmacol Ther; 2006 Feb; 23(4):521-9. PubMed ID: 16441473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a four-graded scale for severity of heartburn in patients with symptoms of gastroesophageal reflux disease.
    Junghard O; Wiklund I
    Value Health; 2008; 11(4):765-70. PubMed ID: 18194395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic overview of the use of diary cards, quality-of-life questionnaires, and psychometric tests in treatment trials of Helicobacter pylori-positive and -negative non-ulcer dyspepsia.
    Sandha GS; Hunt RH; Veldhuyzen van Zanten SJ
    Scand J Gastroenterol; 1999 Mar; 34(3):244-9. PubMed ID: 10232867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double blind, randomized, placebo-controlled trial of proton pump inhibitor therapy in patients with uninvestigated dyspepsia.
    Rabeneck L; Souchek J; Wristers K; Menke T; Ambriz E; Huang I; Wray N
    Am J Gastroenterol; 2002 Dec; 97(12):3045-51. PubMed ID: 12492188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of profound acid suppression in functional dyspepsia: a double-blind, randomized, placebo-controlled trial.
    Bolling-Sternevald E; Lauritsen K; Aalykke C; Havelund T; Knudsen T; Unge P; Ekström P; Jaup B; Norrby A; Stubberöd A; Melén K; Carlsson R; Jerndal P; Junghard O; Glise H
    Scand J Gastroenterol; 2002 Dec; 37(12):1395-402. PubMed ID: 12523588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia.
    Koskenpato J; Farkkilä M; Sipponen P
    Am J Gastroenterol; 2001 Oct; 96(10):2866-72. PubMed ID: 11693319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of upper endoscopy on satisfaction in patients with previously uninvestigated dyspepsia.
    Rabeneck L; Wristers K; Souchek J; Ambriz E
    Gastrointest Endosc; 2003 Mar; 57(3):295-9. PubMed ID: 12612505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial linguistic and psychometric validation of the Arabic version of Nepean Dyspepsia Index.
    Khalil MS; Wahass SH; Al-Qourain AA; Yassawy MI
    Saudi Med J; 2006 Oct; 27(10):1554-60. PubMed ID: 17013482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the Leuven Postprandial Distress Scale, a questionnaire for symptom assessment in the functional dyspepsia/postprandial distress syndrome.
    Carbone F; Vandenberghe A; Holvoet L; Vanuytsel T; Van Oudenhove L; Jones M; Tack J
    Aliment Pharmacol Ther; 2016 Nov; 44(9):989-1001. PubMed ID: 27518319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a short questionnaire in English and French for use in patients with persistent upper gastrointestinal symptoms despite proton pump inhibitor therapy: the PASS (Proton pump inhibitor Acid Suppression Symptom) test.
    Armstrong D; Veldhuyzen SJ; Chung SA; Shapiro CM; Dhillon S; Escobedo S; Chakraborty BK; Mann V; Tanser L; Nevin K
    Can J Gastroenterol; 2005 Jun; 19(6):350-8. PubMed ID: 15997268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cure of Helicobacter pylori infection does not improve symptoms in non-ulcer dyspepsia patients-a double-blind placebo-controlled study.
    Miwa H; Hirai S; Nagahara A; Murai T; Nishira T; Kikuchi S; Takei Y; Watanabe S; Sato N
    Aliment Pharmacol Ther; 2000 Mar; 14(3):317-24. PubMed ID: 10735925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group.
    Talley NJ; Janssens J; Lauritsen K; Rácz I; Bolling-Sternevald E
    BMJ; 1999 Mar; 318(7187):833-7. PubMed ID: 10092259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a gastro-protective agent, rebamipide, on symptom improvement in patients with functional dyspepsia: a double-blind placebo-controlled study in Japan.
    Miwa H; Osada T; Nagahara A; Ohkusa T; Hojo M; Tomita T; Hori K; Matsumoto T; Sato N
    J Gastroenterol Hepatol; 2006 Dec; 21(12):1826-31. PubMed ID: 17074021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical presentation and personality factors are predictors of the response to treatment in patients with functional dyspepsia; a randomized, double-blind placebo-controlled crossover study.
    Holtmann G; Kutscher SU; Haag S; Langkafel M; Heuft G; Neufang-Hueber J; Goebell H; Senf W; Talley NJ
    Dig Dis Sci; 2004 Apr; 49(4):672-9. PubMed ID: 15185877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Leeds HELP Study Group.
    Moayyedi P; Feltbower R; Brown J; Mason S; Mason J; Nathan J; Richards ID; Dowell AC; Axon AT
    Lancet; 2000 May; 355(9216):1665-9. PubMed ID: 10905240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does endoscopy have a positive impact on quality of life in dyspepsia?
    Wiklund I; Glise H; Jerndal P; Carlsson J; Talley NJ
    Gastrointest Endosc; 1998 Jun; 47(6):449-54. PubMed ID: 9647367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised clinical trial: the clinical efficacy and safety of an alginate-antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China.
    Sun J; Yang C; Zhao H; Zheng P; Wilkinson J; Ng B; Yuan Y
    Aliment Pharmacol Ther; 2015 Oct; 42(7):845-54. PubMed ID: 26228097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies).
    Talley NJ; Meineche-Schmidt V; Paré P; Duckworth M; Räisänen P; Pap A; Kordecki H; Schmid V
    Aliment Pharmacol Ther; 1998 Nov; 12(11):1055-65. PubMed ID: 9845395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.